Single-Use Systems

Jun 13, 2018
By BioPharm International Editors
WuXi Biologics will invest $60 million to establish a biologics production facility in Massachusetts.
Jun 07, 2018
By BioPharm International Editors
The company will provide the first FlexFactory manufacturing platform for TCR T-cell therapy manufacturing.
May 29, 2018
By BioPharm International Editors
This marks the third FDA approval for the company’s second biomanufacturing plant in Incheon, Korea.
May 17, 2018
By BioPharm International Editors
Parker Bioscience will expand laboratory, cleanroom, office, and warehouse facilities at its Birtley, UK manufacturing site.
May 03, 2018
By BioPharm International Editors
The company will invest EUR 325 million (US$389 million) in a new biomanufacturing facility in Ireland using single-use bioreactors.
May 01, 2018
BioPharm International
More published data and initial regulatory approvals are needed to drive adoption of continuous bio-manufacturing.
Apr 19, 2018
By BioPharm International Editors
The company unveiled three new products to support single-use biomanufacturing and won an award for best technological innovation at INTERPHEX 2018.
Apr 17, 2018
By BioPharm International Editors
The company is launching a new pre-fabricated, ready-to-run manufacturing facility that is expected to significantly decrease the production timeline for viral vector-based therapeutics.
Apr 17, 2018
By BioPharm International Editors
Industry experts will discuss lyophilization best practices and continuous manufacturing for biopharmaceuticals.
Apr 11, 2018
By BioPharm International Editors
The biopharmaceutical firm has chosen Rhode Island as the site of its next-generation biomanufacturing plant, which will offer flexibility, speed, and efficiency.
native1_300x100
lorem ipsum